+86 189 1304 2753 product@eynoslifescience.com

T cells are the most forgiving population to isolate and the least forgiving to activate. Negative selection keeps the TCR untouched; CD3/CD28 beads replace feeder cells; polarisation conditions decide the subset; and the killing assay decides whether any of it meant anything.

1

T-cell biology: the framework

T lymphocytes mature in the thymus and carry a clonotypic TCR that reads peptide presented on MHC. This overview covers thymic selection and repertoire construction, the three-signal model of activation, effector subset division of labour and immunological memory.

Read the protocol
2

T-cell isolation (negative selection), activation and expansion

Negative selection leaves the target T cells untouched by bead and antibody, which is why it is the default for functional work. The protocol runs from sample preparation through column-free isolation to CD3/CD28 activation, for both human PBMC and mouse spleen.

Read the protocol
3

CFSE proliferation assay for mouse T cells

CFSE dilution halves the dye with every division, producing the staircase of peaks used to reconstruct proliferation history. The protocol combines column-free isolation with bead activation and covers labelling through to peak readout.

Read the protocol
4

Treg induction and polarisation

Regulatory T cells are defined by CD4⁺CD25⁺FoxP3⁺ and act as the negative control arm of immune tolerance. Covers Treg biology, the three requirements for in vitro induction, and how to verify suppressive function rather than only FoxP3 percentage.

Read the protocol
5

Th1 polarisation

Th1 cells are marked by IFN-γ secretion and defined by the transcription factor T-bet, and they drive cell-mediated immunity against intracellular pathogens and tumours. Covers the polarisation signalling and the readouts that confirm it.

Read the protocol
6

Th2 polarisation

Th2 cells are marked by IL-4, IL-5 and IL-13 and governed by GATA3; they mediate humoral immunity, anti-parasite responses and allergic inflammation. Covers the polarisation protocol and the verification strategy.

Read the protocol
7

CAR-T design, screening and functional verification

From scFv discovery and screening through CAR–antigen affinity measurement and transmembrane or intracellular domain customisation, to target-cell preparation and in vitro and in vivo verification — the six stages of CAR development and the control point in each.

Read the protocol
8

T-cell killing 1: CAR-T cytotoxicity assay

The classical in vitro model for CAR-T function: effectors co-cultured with antigen-positive tumour cells across an effector-to-target gradient, quantified by luciferase, LDH release or flow-based apoptosis staining, with an antigen-negative control for specificity.

Read the protocol
9

T-cell killing 2: T cell–tumour co-culture

A TCR-dependent model that does not require a CAR: antigen-specific (OT-1) or polyclonally activated CD8⁺ CTLs co-cultured with tumour cells, read for killing and cytokine release. The standard tool for tumour immunogenicity and immune-drug screening.

Read the protocol
10

T-cell depletion

When the experiment needs T cells removed rather than recovered — enriching non-T populations, building an immunodeficient background, or modelling GVHD in vitro — a biotinylated antibody plus streptavidin bead workflow removes CD3, CD4 or CD8 positive cells.

Read the protocol

Matching products

The catalogue numbers used in these protocols, all with a numbered manual and lot-level COA.

10 protocols in this category. Each one opens with the starting material and closes with the readout that proves the population is what you think it is.

Tell us the species, the starting material and the readout

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.